Biocon Limited (NSE:BIOCON)

Biocon Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 11, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	604,016	584,070	408,948	315,392	246,192	399,173
Market Cap Growth	17.54%	42.82%	29.66%	28.11%	-38.32%	-17.63%
Enterprise Value	757,259	750,906	607,421	513,003	277,130	425,255
Last Close Price	370.95	360.47	340.84	263.12	204.36	331.82

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 11, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	126.18	151.47	40.36	30.85	53.21	61.56
Forward PE	68.19	61.80	56.28	34.10	21.39	35.74
PS Ratio	3.47	3.45	2.68	2.14	2.20	4.88
PB Ratio	1.63	1.60	1.48	1.25	1.10	4.22
P/TBV Ratio	11.06	11.18	-	-	-	5.61
P/FCF Ratio	180.46	297.84	21.25	24.77	95.98	-
P/OCF Ratio	30.82	29.29	10.07	10.68	13.29	33.93
PEG Ratio	1.33	1.07	1.57	1.19	0.59	1.20

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 11, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	4.35	4.44	3.98	3.48	2.48	5.20
EV/EBITDA Ratio	20.60	21.27	19.44	15.68	10.43	21.74
EV/EBIT Ratio	47.70	44.32	39.36	28.77	17.72	36.71
EV/FCF Ratio	226.25	382.92	31.56	40.29	108.04	-

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 11, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	0.42	0.42	0.66	0.64	0.80	0.54
Debt / EBITDA Ratio	4.27	4.29	5.77	4.91	6.73	2.61
Debt / FCF Ratio	46.90	78.71	9.54	12.78	70.25	-
Net Debt / Equity Ratio	0.35	0.32	0.50	0.54	0.64	0.23
Net Debt / EBITDA Ratio	3.61	3.27	4.42	4.19	5.38	1.12
Net Debt / FCF Ratio	38.87	58.90	7.17	10.76	55.72	-4.19
Asset Turnover	0.27	0.28	0.27	0.27	0.31	0.42
Inventory Turnover	1.04	1.21	1.22	1.22	1.29	1.52
Quick Ratio	0.59	0.71	0.71	0.58	0.87	1.43
Current Ratio	1.22	1.22	1.14	0.99	1.45	2.19
Return on Equity (ROE)	0.97%	1.15%	5.39%	5.43%	4.02%	8.58%
Return on Assets (ROA)	1.55%	1.73%	1.68%	2.06%	2.70%	3.72%
Return on Invested Capital (ROIC)	3.03%	3.11%	2.90%	4.01%	4.63%	8.49%
Return on Capital Employed (ROCE)	3.10%	3.40%	3.50%	4.40%	3.60%	7.00%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 11, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	0.79%	0.66%	2.48%	3.24%	1.88%	1.62%
FCF Yield	0.55%	0.34%	4.71%	4.04%	1.04%	-1.31%
Dividend Yield	0.13%	0.14%	0.15%	0.19%	0.73%	0.15%
Payout Ratio	18.07%	17.35%	5.92%	19.85%	12.95%	-
Buyback Yield / Dilution	-23.57%	-14.22%	-0.11%	-0.08%	0.04%	0.03%
Total Shareholder Return	-23.43%	-14.08%	0.03%	0.11%	0.76%	0.18%

Data Source: S&P Global Market Intelligence Last updated: Nov 4, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 10, 2026

Data Sources Report a data error